Clinical Trial Update: Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and effectiveness of Rilonacept for systemic juvenile idiopathic arthritis in children and young adults; results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Juvenile Idiopathic Arthritis

Drugs mentioned

• Rilonacept (Arcalyst) (rilonacept)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Juvenile Idiopathic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2015-12-11